Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Enters Deal to Bring Diagnostic Product to Market

SAN FRANCISCO, Dec. 17 - Caliper Technologies has entered into a deal with Bacterial BarCodes to develop and co-distribute a clinical diagnostic system to detect and diagnose invasive bacterial infections, the companies said on Monday.


It is the first commercial diagnostics deal for Mountain View, Calif.-based Caliper, according to the company.


In the agreement, Caliper will combine its LabChip DNA analysis reagents and chips with Bacterial BarCodes' rep-PCR reagents in a diagnostic kit to be sold by Houston, Texas-based Bacterial BarCodes. Kit customers will have access to Bacterial BarCodes' database of bacterial fingerprints. The instruments that process the kit's chips will be marketed and sold by Caliper.


Financial details of the agreement were not disclosed.


"This collaboration with Bacterial BarCodes marks Caliper's entry into the diagnostics field, a large and growing potential market for our LabChip products," said Dan Kisner, CEO of Caliper. "Caliper intends to pursue additional strategic commercial alliances with the goal of enabling other innovative market leaders to incorporate LabChip capabilities into their product development and commercialization programs."


Bacterial BarCodes is a spin-off company of BCM Technologies, a venture development subsidiary of Baylor College of Medicine.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.